Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen

Journal of Hepatology

Volumn 52, Issue 3, 2010, Pages 463-465

  Hung, Hung Hsu ^a   Su, Chien Wei ^a,b   Wu, Jaw Ching ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B SURFACE ANTIBODY;

AGED; ANTIBODY BLOOD LEVEL; BIOCHEMISTRY; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT REFUSAL; TUMOR VOLUME; VIRUS REACTIVATION;

AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; GUANINE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 77249146853     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.11.023     Document Type: Letter

References (7)

1. Sanchez M.J., Buti M., Homs M., Palacios A., Rodriguez-Frias F., and Esteban R. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab. J Hepatol 51 (2009) 1091-1096
2. Hsu C., Hsiung C.A., Su I.J., Hwang W.S., Wang M.C., Lin S.F., et al. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology 47 (2008) 844-853
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50 (2009) 227-242
4. Yeo W., Chan T.C., Leung N.W., Lam W.Y., Mo F.K., Chu M.T., et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 27 (2009) 605-611
5. Jang J.W., Choi J.Y., Bae S.H., Yoon S.K., Chang U.I., Kim C.W., et al. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization. Hepatology 43 (2006) 233-240
6. Wu J.M., Huang Y.H., Lee P.C., Lin H.C., and Lee S.D. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma. J Clin Gastroenterol 43 (2009) 496-498
7. Jang J.W., Choi J.Y., Bae S.H., Kim C.W., Yoon S.K., Cho S.H., et al. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol 41 (2004) 427-435